rxstat › Shortages › Insulin Glargine

Insulin Glargine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Reports by product

Showing 12 of 22 reports. All reports are on file with Health Canada.

What's happening

Insulin Glargine is currently affected by an active shortage report filed with Health Canada by SANOFI-AVENTIS CANADA INC.

The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Insulin Glargine is classified under “INSULINS AND ANALOGUES” (ATC A10AE).

Recent changes

• No changes recorded yet.

Common questions

Related drugs (insulins and analogues)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.